BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16633151)

  • 1. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.
    Hedenmalm K; Güzey C; Dahl ML; Yue QY; Spigset O
    J Clin Psychopharmacol; 2006 Apr; 26(2):192-7. PubMed ID: 16633151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.
    Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O
    Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
    Tybura P; Trześniowska-Drukała B; Bienkowski P; Beszlej A; Frydecka D; Mierzejewski P; Samochowiec A; Grzywacz A; Samochowiec J
    Psychiatry Res; 2014 Oct; 219(2):261-7. PubMed ID: 24930580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients.
    Nakazono Y; Abe H; Murakami H; Koyabu N; Isaka Y; Nemoto Y; Murata S; Tsutsumi Y; Ohtani H; Sawada Y
    Int J Clin Pharmacol Ther; 2005 Apr; 43(4):163-71. PubMed ID: 15966462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population.
    Güzey C; Lopez-Rodriguez R; Myhre R; Spigset O
    Genet Test Mol Biomarkers; 2011; 15(7-8):557-63. PubMed ID: 21453053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
    Mas S; Gassó P; Lafuente A; Bioque M; Lobo A; Gonzàlez-Pinto A; Olmeda MS; Corripio I; Llerena A; Cabrera B; Saiz-Ruiz J; Bernardo M;
    Pharmacogenomics J; 2016 Oct; 16(5):439-45. PubMed ID: 27272046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.
    Lane RM
    J Psychopharmacol; 1998; 12(2):192-214. PubMed ID: 9694033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports.
    Schillevoort I; van Puijenbroek EP; de Boer A; Roos RA; Jansen PA; Leufkens HG
    Int Clin Psychopharmacol; 2002 Mar; 17(2):75-9. PubMed ID: 11892721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
    Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
    Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil.
    Vasconcelos AC; Neto Ede S; Pinto GR; Yoshioka FK; Motta FJ; Vasconcelos DF; Canalle R
    Alcohol Clin Exp Res; 2015 Feb; 39(2):205-11. PubMed ID: 25684044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes.
    Gassó P; Mas S; Crescenti A; Alvarez S; Parramon G; Garcia-Rizo C; Parellada E; Bernardo M; Lafuente A
    Psychiatry Res; 2010 Jan; 175(1-2):173-5. PubMed ID: 19892410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.
    Nemoda Z; Lyons-Ruth K; Szekely A; Bertha E; Faludi G; Sasvari-Szekely M
    Behav Brain Funct; 2010 Jan; 6():4. PubMed ID: 20205808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
    Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans.
    Konishi T; Calvillo M; Leng AS; Lin KM; Wan YJ
    Alcohol; 2004 Jan; 32(1):45-52. PubMed ID: 15066703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Catalan R; Mateos JJ; Lomeña F; Parellada E
    Schizophr Res; 2007 Feb; 90(1-3):115-22. PubMed ID: 17150335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of dopamine D2, D4 receptor gene, GABAA receptor beta subunit gene, serotonin transporter gene polymorphism with children of alcoholics in Korea: a preliminary study.
    Namkoong K; Cheon KA; Kim JW; Jun JY; Lee JY
    Alcohol; 2008 Mar; 42(2):77-81. PubMed ID: 18358985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.